{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:19Z","timestamp":1753890499336,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2018C04011"],"award-info":[{"award-number":["2018C04011"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to investigate the prevalence and factors associated with the initiation of oral anticoagulation among patients with acute ischemic stroke (AIS) and concurrent atrial fibrillation (AF) at discharge in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We continuously included hospitalized patients with AIS with an AF diagnosis registered in the computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation (CASE II) from January 2016 to December 2020 and divided them into a and non-anticoagulant groups according to the medications at discharge. Binary logistic regression was used to determine the factors associated with the prescription of anticoagulants in patients with AF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 16,162 patients were enrolled. The mean age was 77 \u00b1 9 years, 8,596 (53.2%) were males, and the median baseline National Institute of Health Stroke Scale score was 5 (2\u201312). Of the 14,838 patients without contraindications of antithrombotic therapy, 6,335 (42.7%) patients were initiated with anticoagulation treatment at discharge. Prior history of hemorrhagic stroke (OR 0.647, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and gastrointestinal bleeding (OR 0.607, <jats:italic>p<\/jats:italic> = 0.003) were associated with a lower rate of anticoagulation at discharge. Patients with any intracranial hemorrhage (OR 0.268, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), gastrointestinal bleeding (OR 0.353, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), or pneumonia during hospitalization (OR 0.601, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) were less likely to receive anticoagulants at discharge. Among 7,807 patients with previously diagnosed AF and high risk of stroke (CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc \u22652), only 1,585 (20.3%) had been receiving anticoagulation treatment prior to the onset of stroke. However, the mean international normalized ratio (INR) was 1.5 on the first test during hospitalization in patients receiving warfarin. Patients complicated with a previous history of ischemic stroke\/transient ischemic attack (TIA; OR 2.303, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and peripheral artery disease (OR 1.456, <jats:italic>p<\/jats:italic> = 0.003) were more common to start anticoagulants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Less than half of patients with AIS and concurrent AF initiated guideline-recommended oral anticoagulation at discharge, while only 20% of patients with previously diagnosed AF with a high risk of stroke had been using anticoagulants prior to the onset of stroke, which highlights a large care gap in hospitalized stroke patients and the importance of AF management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.841020","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:30:28Z","timestamp":1648650628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation"],"prefix":"10.3389","volume":"9","author":[{"given":"Xiaoxian","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wansi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1161\/CIR.0000000000000041","article-title":"2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost."},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12959-018-0177-1","article-title":"Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study","volume":"16","author":"Gebreyohannes","year":"2018","journal-title":"Thromb J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijcard.2015.09.006","article-title":"Paroxysmal atrial fibrillation and the hazards of under-treatment","volume":"202","author":"Aronis","year":"2016","journal-title":"Int J Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/clc.22133","article-title":"Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey","volume":"36","author":"Brandes","year":"2013","journal-title":"Clin Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1003146","DOI":"10.1371\/journal.pmed.1003146","article-title":"Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): a prospective multicenter study","volume":"17","author":"Chen","year":"2020","journal-title":"PLoS Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"117410","DOI":"10.1016\/j.jns.2021.117410","article-title":"Adherence to anticoagulant guideline for atrial fibrillation: a large care gap among stroke patients in a rural population","volume":"424","author":"Diaz","year":"2021","journal-title":"J Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ijcard.2016.08.236","article-title":"Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry","volume":"223","author":"Oh","year":"2016","journal-title":"Int J Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/europace\/euw073","article-title":"Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort","volume":"18","author":"Huisman","year":"2016","journal-title":"Europace."},{"key":"B10","first-page":"833","article-title":"Building structured personal health records from photographs of printed medical records","volume":"2015","author":"Li","year":"2015","journal-title":"AMIA Annu Symp Proc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders","volume":"20","year":"1989","journal-title":"Stroke."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/1747493017743062","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines, update 2017","volume":"13","author":"Wein","year":"2018","journal-title":"Int J Stroke."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/ene.12820","article-title":"Underuse of anticoagulation in stroke patients with atrial fibrillation\u2013the FibStroke Study","volume":"23","author":"Palomaki","year":"2016","journal-title":"Eur J Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijcard.2014.11.182","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal","volume":"180","author":"Lip","year":"2015","journal-title":"Int J Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2016-08-731638","article-title":"Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy","volume":"129","author":"Lopes","year":"2017","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehv476","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O'Brien","year":"2015","journal-title":"Eur Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.5603\/KP.2016.0172","volume":"74","author":"Kirchhof","year":"2016","journal-title":"Kardiol Pol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehab648","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/eurheartj\/eht134","article-title":"EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary","volume":"34","author":"Heidbuchel","year":"2013","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.STR.14.5.688","article-title":"Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study","volume":"14","author":"Hart","year":"1983","journal-title":"Stroke."},{"key":"B28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke."},{"key":"B30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00415-015-7957-3","article-title":"Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study","volume":"263","author":"Paciaroni","year":"2016","journal-title":"J Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/STROKEAHA.116.015770","article-title":"Prediction of early recurrent thromboembolic event and major bleeding in patients with acute stroke and atrial fibrillation by a risk stratification schema: the ALESSA score study","volume":"48","author":"Paciaroni","year":"2017","journal-title":"Stroke."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","article-title":"Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial","volume":"74","author":"Hong","year":"2017","journal-title":"JAMA Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","article-title":"Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation","volume":"18","author":"Seiffge","year":"2019","journal-title":"Lancet Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1161\/STROKEAHA.116.016146","article-title":"Secondary versus primary stroke prevention in atrial fibrillation: insights from the darlington atrial fibrillation registry","volume":"48","author":"Mazurek","year":"2017","journal-title":"Stroke."},{"key":"B37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/europace\/euv242","article-title":"Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings","volume":"18","author":"Mikkelsen","year":"2016","journal-title":"Europace."},{"key":"B38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1159\/000350199","article-title":"Stroke-associated pneumonia: major advances and obstacles","volume":"35","author":"Hannawi","year":"2013","journal-title":"Cerebrovasc Dis."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.841020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:30:32Z","timestamp":1648650632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.841020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2022.841020"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.841020","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"article-number":"841020"}}